Disease: Prolactinoma- familial
- <em>PAM</em> variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas
- A case of giant prolactinoma and pituitary hemorrhage with the late recovery of pituitary function: A case report
- A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
- A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma
- ADAM22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma
- Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas
- An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline <em>SDHB</em> pathogenic variant in the absence of paraganglioma or pheochromocytoma
- An algorithm for the treatment of concurrent pituitary adenoma and cavernous sinus aneurysm: A systematic review & case report
- An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction-a case report
- Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review
- Between a rock and a hard place: the role of DA induced tumor fibrosis in prolactinoma management
- C4 to C7 Laminoplasty for Resection of an Intradural Intramedullary Ependymoma: 2-Dimensional Operative Video
- Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
- Case report: Complete restoration of the HPA axis function in Cushing's disease with drug treatment
- Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia
- Challenges in Diagnosis and Treatment of Male Hypogonadism
- Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery
- Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience
- Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study
- Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy
- Clival ectopic pituitary prolactinoma was successfully managed by transsphenoidal surgery: A rare case report
- Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy
- Comparing MRI volume measurement techniques for pituitary macroadenoma: Investigating volume reduction and its relationship with biochemical control
- Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case
- Correction: Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review
- Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
- Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
- Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
- Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes
- Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series
- Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease
- Endoscopic Endonasal Transcavernous Hemipituitary Transposition for Resection of Invasive Prolactinoma: 2-Dimensional Operative Video
- Evaluation of pulmonary side effects in prolactinoma patients treated with cabergoline
- Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience
- Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses
- Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility
- Genetic testing in prolactinomas: a cohort study
- Giant prolactinoma in Asian-Indians: A single-center experience from Western India
- Giant prolactinomas, a detailed analysis of 196 adult cases
- Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis
- Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study
- Impulse Control Disorders in Patients with Pituitary Tumors Treated with Dopamine Agonists: A Systematic Review
- Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas
- Invasive Giant Prolactinoma
- Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism
- Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?
- Metabolic Abnormalities, Inflammatory Markers and Endothelial Dysfunction in Hyperprolactinemia due to Prolactinoma before and after Normalization of Serum Prolactin: A Prospective Case Control Study
- Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center
- Metabolic Disorders During Prolactinomas
- Metastatic pituitary neuroendocrine neoplasms: A case report of a malignant prolactinoma
- Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study
- Overcoming therapy resistance in prolactinomas: from perspectives to real clinical practice
- Pediatric Cluster Headache Case Series: Symptomatic Cases and the Migraine Relationship
- Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas
- Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers
- Pituitary Adenoma Prevalence and Characteristics of Omani Patients: A Single Center Experience
- Pituitary adenomas registry in Thailand
- Pituitary apoplexy during pregnancy with transsphenoidal resection and intraoperative fetal monitoring: A case report
- Pituitary apoplexy in endocrinologically silent adenoma during somatostatin analog administration for pancreatic neuroendocrine tumor: A case report
- Pituitary Apoplexy-Associated Cerebral Salt Wasting Syndrome: A Case Report and Literature Review
- Pituitary dysfunction following mild traumatic brain injury in female athletes
- Pituitary macroadenoma with panhypopituitarism masquerading as schizophrenia: a diagnostic dilemma managed conservatively
- Pituitary tumor registry: a multidisciplinary program protocol
- Pregnancy-induced prolactinoma enlargement
- Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics from 290 Cases
- Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
- Primary Sellar Neuroblastoma Masquerading as a Pituitary Macroadenoma
- Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
- Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
- Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center
- Prolactinoma and Adenomyosis - More than Meets the Eye: A Case Report
- Prolactinoma in postmenopausal women: a systematic review
- Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment
- Quality of life in Prolactinoma: A systematic review
- Reply to 'Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern'
- Role of Immediate Postoperative Prolactin Measurement in Female Prolactinoma Patients: Predicting Long-Term Remission After Complete Tumor Removal
- Ropinirole for the Treatment of Hyperprolactinemia: A Dose Escalation Study of Efficacy and Tolerability
- Serum prolactin levels and mortality in adults without prolactinoma: A meta-analysis
- Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients
- Stereotactic Radiosurgery Outcomes in Medically and Surgically Failed or Nonsurgical Candidates with Medically Failed Prolactinomas: A Systematic Review and Meta-Analysis
- Suddenly confused: Necessity for timely follow-up after elective prolactinoma resection
- Surveillance imaging strategies for pituitary adenomas: when, how frequent and when to stop
- Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop
- Synchronous presentation of prolactinoma and supratentorial tanycytic ependymoma
- Syndrome of inappropriate antidiuretic hormone with recurrent giant cabergoline-resistant prolactinoma
- TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA
- The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <em>aryl hydrocarbon receptor interacting protein</em> (AIP) gene
- The Effect of Antipsychotics on Prolactinoma Growth: A Radiological and Serological Analysis
- The Hook Effect: A Case Study of a Giant Invasive Prolactinoma With Falsely Low Serum Prolactin
- The importance of measuring prolactin prior to surgical management of a pituitary lesion: An illustrative case
- The lateral transorbital approach to the medial sphenoid wing, anterior clinoid, middle fossa, cavernous sinus, and Meckel's cave: target-based classification, approach-related complications, and intermediate-term ocular outcomes
- The RAPID Consortium: A Platform for Clinical and Translational Pituitary Tumor Research
- The Role of Artificial Intelligence in Endocrine Management: Assessing ChatGPT's Responses to Prolactinoma Queries
- The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report
- The Use of the Suboccipital Transtentorial Approach to the Posterior Inferior Incisural Space
- The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations
- Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
- Title: Giant Prolactinoma in Asian-Indians: a single-center experience from Western India
- Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
- Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern